These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

332 related articles for article (PubMed ID: 19273152)

  • 1. Immunosuppression for lung transplantation.
    Ng CY; Madsen JC; Rosengard BR; Allan JS
    Front Biosci (Landmark Ed); 2009 Jan; 14(5):1627-41. PubMed ID: 19273152
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immunosuppression for lung transplantation.
    Allan JS
    Semin Thorac Cardiovasc Surg; 2004; 16(4):333-41. PubMed ID: 15635537
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Long-term outcomes and management of lung transplant recipients.
    Costa J; Benvenuto LJ; Sonett JR
    Best Pract Res Clin Anaesthesiol; 2017 Jun; 31(2):285-297. PubMed ID: 29110800
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Heart and lung transplantation in children.
    Webber SA; McCurry K; Zeevi A
    Lancet; 2006 Jul; 368(9529):53-69. PubMed ID: 16815380
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Contemporary lung transplantation: the UCLA experience.
    Sherman W; Rabkin D; Ross D; Ardehali A;
    Clin Transpl; 2008; ():163-70. PubMed ID: 19708455
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evolving immunosuppressive regimens for lung transplant recipients.
    Meyer NJ; Bhorade SM
    Semin Respir Crit Care Med; 2006 Oct; 27(5):470-9. PubMed ID: 17072795
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Emerging drugs in lung transplantation.
    Mankidy B; Kesavan RB; Silay YS; Haddad TJ; Seethamraju H
    Expert Opin Emerg Drugs; 2007 Mar; 12(1):61-73. PubMed ID: 17355214
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Natural killer cells and lung transplantation, roles in rejection, infection, and tolerance.
    Fildes JE; Yonan N; Leonard CT
    Transpl Immunol; 2008 Apr; 19(1):1-11. PubMed ID: 18346631
    [TBL] [Abstract][Full Text] [Related]  

  • 9. From immunosuppression to tolerance.
    Adams DH; Sanchez-Fueyo A; Samuel D
    J Hepatol; 2015 Apr; 62(1 Suppl):S170-85. PubMed ID: 25920086
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Newer therapeutic interventions for pulmonary transplant rejection.
    Barbers RG
    Curr Opin Pulm Med; 1997 Sep; 3(5):366-71. PubMed ID: 9331539
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Kidney transplantation under a tolerogenic regimen of recipient pretreatment and low-dose postoperative immunosuppression with subsequent weaning.
    Shapiro R; Jordan ML; Basu A; Scantlebury V; Potdar S; Tan HP; Gray EA; Randhawa PS; Murase N; Zeevi A; Demetris AJ; Woodward J; Marcos A; Fung JJ; Starzl TE
    Ann Surg; 2003 Oct; 238(4):520-5; discussion 525-7. PubMed ID: 14530723
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Current trends in immunosuppression for lung transplantation.
    Floreth T; Bhorade SM
    Semin Respir Crit Care Med; 2010 Apr; 31(2):172-8. PubMed ID: 20354930
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immunosuppressive Therapy in Lung Transplantation.
    Fernandez-Castillo JC; Cypel M
    Curr Pharm Des; 2020; 26(28):3385-3388. PubMed ID: 32600225
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Thioredoxin priming prolongs lung allograft survival by promoting immune tolerance.
    Hu H; Zhu X; Joshi S; Lu L; Xia CQ; Patel JM
    PLoS One; 2015; 10(5):e0124705. PubMed ID: 25933390
    [TBL] [Abstract][Full Text] [Related]  

  • 15. New developments in treatment after lung transplantation.
    Benden C; Danziger-Isakov L; Faro A
    Curr Pharm Des; 2012; 18(5):737-46. PubMed ID: 22283768
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immunologic consequences of transplantation.
    Keenan RJ; Zeevi A
    Chest Surg Clin N Am; 1995 Feb; 5(1):107-20. PubMed ID: 7743142
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Management of lung transplant rejection.
    Trulock EP
    Chest; 1993 May; 103(5):1566-76. PubMed ID: 8486045
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Induction type and outcomes for kidney graft and patient survival in recipients with prior lung transplantation in the United States.
    Riad S; Goswami U; Jackson S; Hertz M; Matas A
    J Heart Lung Transplant; 2020 Feb; 39(2):157-164. PubMed ID: 31837899
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Belatacept for maintenance immunosuppression in cardiothoracic transplantation: The potential frontier.
    Ensor CR; Goehring KC; Iasella CJ; Moore CA; Lendermon EA; McDyer JF; Morrell MR; Sciortino CM; Venkataramanan R; Wiland AM
    Clin Transplant; 2018 Oct; 32(10):e13363. PubMed ID: 30058177
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Malignancy After Lung Transplantation: How to Manage Immunosuppression?
    Wang X; Dong M
    Transplant Proc; 2020; 52(1):315-320. PubMed ID: 31948800
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.